A Thrombin Inhibitor
A Wnt Pathway Modulator
"We are committed to creating a valuable product-focused company that leverages our drug discovery and development expertise. Nuvelo has the product opportunities and the human and financial resources to execute this strategy."
Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers
Nuvelo and ARCA biopharma Advance Toward Completion of Merger
ARCA biopharma to Present at Rodman & Renshaw Tenth Annual Healthcare Conference